ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

RGLS Regulus Therapeutics Inc

2.69
0.00 (0.00%)
Pre Market
Last Updated: 03:03:42
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Regulus Therapeutics Inc RGLS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 2.69 03:03:42
Open Price Low Price High Price Close Price Previous Close
2.69
more quote information »

Recent News

Date Time Source Heading
4/30/202407:00PRNUSRegulus Therapeutics to Participate in the Canaccord Genuity..
3/21/202415:05PRNUSRegulus Therapeutics Reports Fourth Quarter and Year-End..
3/12/202405:32PRNUSRegulus Therapeutics Announces Oversubscribed $100 Million..
3/12/202405:30PRNUSRegulus Therapeutics Announces Positive Topline Data from..
1/18/202419:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/18/202419:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/17/202416:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/17/202416:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/12/202415:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
1/09/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
1/02/202415:05PRNUSRegulus Therapeutics Announces Completion of Enrollment in..
12/27/202315:16EDGAR2Form S-3 - Registration statement under Securities Act of..
11/22/202307:00PRNUSRegulus Therapeutics to Present at the 6th Annual Evercore..
11/09/202315:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202315:15EDGAR2Form 8-K - Current report
11/09/202315:05PRNUSRegulus Therapeutics Reports Third Quarter 2023 Financial..
11/02/202307:00PRNUSRegulus Therapeutics Announces First Patient Dosed in Third..
10/19/202307:00PRNUSRegulus Therapeutics Advances to Cohort 3 of Phase 1b..
9/20/202306:00PRNUSRegulus Therapeutics Announces Positive Topline Data from..
9/13/202307:00PRNUSRegulus Therapeutics Announces Completion of Enrollment in..
9/05/202307:00PRNUSRegulus Therapeutics Announces Participation at Two..
8/23/202307:00PRNUSRegulus Therapeutics to Host Virtual Investor Event on..
8/14/202315:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/14/202315:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/14/202315:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/14/202315:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/14/202315:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/14/202315:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/08/202315:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202315:15EDGAR2Form 8-K - Current report
8/08/202315:05PRNUSRegulus Therapeutics Reports Second Quarter 2023 Financial..
8/02/202307:00PRNUSRegulus Therapeutics to Present at the Canaccord Genuity..
7/18/202307:00PRNUSRegulus Therapeutics to Present at the H.C. Wainwright 2nd..
6/29/202315:53EDGAR2Form S-8 - Securities to be offered to employees in employee..
6/27/202307:00PRNUSRegulus Therapeutics Announces First Patient Dosed in Second..
6/23/202307:00PRNUSRegulus Therapeutics Announces Appointment of Preston S...
6/20/202307:00PRNUSRegulus Therapeutics Announces Update on Preclinical Studies..
6/12/202307:00PRNUSRegulus Therapeutics Strengthens Research & Development..
5/16/202307:00PRNUSRegulus Therapeutics Advances to Cohort 2 of Phase 1b..
5/11/202315:05PRNUSRegulus Therapeutics Reports First Quarter 2023 Financial..

Your Recent History

Delayed Upgrade Clock